Zaitoon, Hussein
Lubetzky, Ronit
Amir, Achiya Z.
Moran-Lev, Hadar
Sagi, Liora
Yacobi-Bach, Michal
Borger, Ophir
Chorna, Efrat
Lebenthal, Yael
Brener, Avivit http://orcid.org/0000-0002-2742-8264
Article History
Received: 28 November 2022
Accepted: 26 April 2023
First Online: 9 May 2023
Declarations
:
: The authors declare that there is no conflict of interest.
: The institutional ethics committee after careful consideration and deliberation in each case approved the off-label use of liraglutide.
: The patients and their parents gave their informed consent to publish their case.